In vivo depletion of CD25+ cells prior to LRAST increases therapeutic efficacy in a murine melanoma model

Similar Items

• Anti-Gr-1 Antibody Provides Short-Term Depletion of MDSC in Lymphodepleted Mice with Active-Specific Melanoma Therapy
  od: Peter Rose, i dr.
  Izdano: (2022-04-01)
• P54. Possible role of MDSC for the induction of tumour-specific T cells following LRAST
  od: Rose, P, i dr.
  Izdano: (2014)
• P53. Effect of lymphodepletion and tumour on host and reconstituted regulatory T-cells in a model of murine melanoma
  od: Kovács, J, i dr.
  Izdano: (2014)
• Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene
  od: Nöckel, Jessica, i dr.
  Izdano: (2006)
• Combination immunotherapy and active-specific tumor cell vaccination augments anti-cancer immunity in a mouse model of gastric cancer
  od: van den Engel, Natasja K, i dr.
  Izdano: (2011)